GLP-1 Receptor Agonist Is Expected To Witness High Growth
Market Dynamics:The increasing prevalence of diabetes is one of the major drivers responsible for the growth of the GLP-1 receptor agonist market. As per the International Diabetes Federation (IDF), approximately 537 million adults (20-79 years) were living with diabetes in 2021, and by 2045 this will rise to 783 million. GLP-1 receptor agonists have significantly helped in managing blood...
0 Commenti
0 condivisioni